The AI boom is setting up the S&P for a third straight year of 20%+ gains. And this unprecedented technology is just getting ...

Elite Pharmaceuticals, with a market capitalization of $531 million, reported a decline in third-quarter revenue for 2024, falling 8% from the previous year. Despite a strong nine-month performance, ...

Frank Laukien; Chairman of the Board, President, Chief Executive Officer; Bruker Corp Gerald Herman; Chief Financial Officer, Executive Vice President; Bruker Corp Good day, and welcome to the Bruker ...

Pricing adjustments are expected from Q2 2025 onwards to offset these increases ... Analysts expressed mixed sentiment, with some concerns about slower Q1 growth and commodity pressures but positive ...

Year-over-year BioSpace data shows there were fewer job postings live on the website in the fourth quarter of 2024, and the ...

Cineplex Inc. reported a notable 15.1% increase in total revenue for the first quarter of 2023, reaching $362.7 million. The company's adjusted EBITDA surged by 66.6% to $40.3 million, reflecting ...

William Blair analyst A. Brackmann anticipates that the medical instruments supplier will post earnings of $3.34 per share for […] ...